Claims that AI will “revolutionise pharma R&D” are (almost entirely) hype
DrugBaron
JANUARY 31, 2024
No surrogate marker (selecting a development candidate, starting human trials, or (arguably) even launching a drug are reliable indicators of the only things that matter: real-world clinical utility and commercial success. Want to know if your AI-identified tweaks to the productivity of your chemical plant do indeed improve output?
165 
Let's personalize your content